61.97
price down icon3.16%   -2.02
pre-market  Vorhandelsmarkt:  60.50   -1.47   -2.37%
loading

Crispr Therapeutics Ag Aktie (CRSP) Neueste Nachrichten

pulisher
05:40 AM

Is CRISPR Therapeutics AG showing signs of accumulationWall Street Watch & Verified Momentum Stock Ideas - newser.com

05:40 AM
pulisher
05:30 AM

Intellectus Partners LLC Makes New $284,000 Investment in CRISPR Therapeutics AG $CRSP - MarketBeat

05:30 AM
pulisher
04:44 AM

Why CRISPR Therapeutics AG (1CG) stock is listed among top recommendationsJuly 2025 Opening Moves & Community Verified Watchlist Alerts - newser.com

04:44 AM
pulisher
03:37 AM

Applying Wyckoff theory to CRISPR Therapeutics AG stockTrade Volume Report & Advanced Swing Trade Entry Plans - newser.com

03:37 AM
pulisher
01:21 AM

Building trade automation scripts for CRISPR Therapeutics AG2025 Market Trends & Safe Swing Trade Setups - newser.com

01:21 AM
pulisher
01:07 AM

Why retail investors favor CRISPR Therapeutics AG stock2025 Performance Recap & Accurate Entry and Exit Point Alerts - newser.com

01:07 AM
pulisher
Nov 03, 2025

Should CRSP Stock Be in Your Portfolio Pre-Q3 Earnings? - Yahoo! Finance Australia

Nov 03, 2025
pulisher
Nov 03, 2025

What to do if you’re stuck in CRISPR Therapeutics AGJuly 2025 Volume & Reliable Price Breakout Alerts - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Has CRISPR Therapeutics AG found a price floorQuarterly Earnings Summary & Reliable Momentum Entry Alerts - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

CRISPR Therapeutics AG stock trendline breakdownPortfolio Performance Report & High Return Trade Opportunity Guides - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Why CRISPR Therapeutics AG stock could rally in 2025July 2025 Decliners & Verified Momentum Stock Ideas - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

How to build a dashboard for CRISPR Therapeutics AG stockJuly 2025 Fed Impact & Smart Investment Allocation Tips - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Visualizing CRISPR Therapeutics AG stock with heatmapsTrade Exit Summary & Free Safe Entry Trade Signal Reports - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Can CRISPR Therapeutics AG (1CG) stock double in coming yearsJuly 2025 Catalysts & Community Consensus Stock Picks - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Can CRISPR Therapeutics AG (1CG) stock deliver double digit returnsJuly 2025 Closing Moves & Momentum Based Trading Signals - newser.com

Nov 03, 2025
pulisher
Nov 02, 2025

Key resistance and support levels for CRISPR Therapeutics AG2025 Market Sentiment & Community Consensus Trade Alerts - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

How big funds are accumulating CRISPR Therapeutics AG (1CG) stock2025 Volume Leaders & Accurate Technical Buy Alerts - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Will CRISPR Therapeutics AG (1CG) stock gain from green policies2025 Market Trends & Technical Confirmation Trade Alerts - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

What valuation multiples suggest for CRISPR Therapeutics AG stock2025 Buyback Activity & Safe Capital Growth Stock Tips - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Is CRISPR Therapeutics AG stock cheap compared to fundamentalsMarket Trend Summary & Daily Oversold Stock Bounce Ideas - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Y Intercept Hong Kong Ltd Makes New $1.91 Million Investment in CRISPR Therapeutics AG $CRSP - MarketBeat

Nov 02, 2025
pulisher
Nov 02, 2025

Wealthfront Advisers LLC Acquires Shares of 6,003 CRISPR Therapeutics AG $CRSP - MarketBeat

Nov 02, 2025
pulisher
Nov 01, 2025

Is CRISPR Therapeutics AG stock a buy for dividend growthJuly 2025 Rallies & Low Drawdown Investment Strategies - newser.com

Nov 01, 2025
pulisher
Oct 31, 2025

Is CRISPR Therapeutics AG stock a top pick in earnings seasonJuly 2025 Gainers & Comprehensive Market Scan Reports - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

CRISPR Therapeutics AG (CRSP) Is a Trending Stock: Facts to Know Before Betting on It - sharewise.com

Oct 31, 2025
pulisher
Oct 31, 2025

CRISPR Therapeutics (CRSP) Gains as FDA Eases Approval Pathway - GuruFocus

Oct 31, 2025
pulisher
Oct 31, 2025

Gene editing therapy companies rise on word of streamlined FDA approval process - Seeking Alpha

Oct 31, 2025
pulisher
Oct 31, 2025

FDA to Expedite Gene-Editing Approval Process, Impacting CRSP - GuruFocus

Oct 31, 2025
pulisher
Oct 31, 2025

FDA Clears Way for Faster Personalized Gene Editing Therapy - Bloomberg.com

Oct 31, 2025
pulisher
Oct 31, 2025

Key metrics from CRISPR Therapeutics AG’s quarterly dataWeekly Trend Report & AI Forecasted Stock Moves - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Visual analytics tools that track CRISPR Therapeutics AG performanceQuarterly Earnings Report & Expert Approved Momentum Trade Ideas - newser.com

Oct 31, 2025
$37.30
price down icon 0.64%
$28.71
price up icon 0.35%
$101.57
price up icon 8.65%
$103.95
price up icon 0.04%
biotechnology ONC
$311.86
price up icon 0.44%
$186.23
price down icon 1.78%
Kapitalisierung:     |  Volumen (24h):